Munich Re Builds Pandemic Underwriting Hub at Lloyd’s as Shares Slump Into Oversold Territory

Munich Re launches pandemic risk consortium at Lloyd's via subsidiary, while shares drop to oversold levels. AGM to vote on €24 dividend and €2.25B buyback.

Munich Re is pressing ahead with a major expansion of its specialty insurance capabilities, establishing a new pandemic risk consortium at the Lloyd’s market in London through its subsidiary Munich Re Specialty. The move comes at a time when the Dax-listed reinsurer’s shares have fallen into technically oversold territory, with the stock closing at €540.80 after shedding nearly five percent over the past week.

The consortium, which builds on the internal “Epidemic Risk Solutions” unit launched back in 2017, is designed to bring greater predictability to one of the most volatile corners of the insurance industry. Dominick Hoare, Group Chief Underwriting Officer at Munich Re Specialty, is spearheading the push to systematise pandemic coverage by introducing a strict three-stage claims trigger. Payouts will only be activated when the World Health Organization officially declares a pandemic, simultaneously calls a public health emergency of international concern, and national authorities impose civil restrictions that disrupt business operations. The aim is to eliminate the protracted claims assessment battles that have historically plagued pandemic-related policies.

The timing of the London initiative is notable. While the operational expansion signals confidence in the specialty segment, the equity market has taken a different view. The stock’s relative strength index has dropped to 26.4, firmly in oversold territory, and the shares now trade roughly 11 percent below their 52-week high of €605.

Portfolio Signal and Dividend Vote

Away from the underwriting floor, Munich Re has been making waves in its asset management operations. SEC filings dated April 26 reveal a dramatic 2,300 percent increase in the group’s position in US software developer Cadence Design Systems, bringing the holding to approximately 11,400 shares. While the market value of roughly $3.6 million is modest relative to the reinsurer’s overall portfolio, the move underscores a strategic tilt toward high-margin US technology names as the group seeks to broaden its investment income streams.

The developments come just days ahead of the company’s 139th annual general meeting, scheduled for April 29 at the ICM in Munich. Shareholders will vote on a proposed dividend of €24.00 per share, which at the current share price of around €541 translates to a yield of roughly 4.4 percent. If approved, the payout is due on May 5, with the ex-dividend date set for April 30.

Immediately following the AGM, Munich Re will launch a new share buyback programme worth up to €2.25 billion, running through April 2027. The capital return plan sits alongside a group net profit target of approximately €6.3 billion for 2026, with the reinsurance segment expected to contribute €5.4 billion. The company is targeting a combined ratio of around 80 percent in its property and casualty business, a level that signals strong underwriting discipline provided major losses remain contained.

Governance Debate Intensifies

Chairman Nikolaus von Bomhard has waded into a growing industry debate over the influence of proxy advisory firms such as ISS and Glass Lewis. He has criticised their blanket opposition to former executives joining supervisory boards, arguing that such rigid guidelines undermine the ability to staff oversight bodies with experienced industry specialists. For Munich Re, the inclusion of seasoned sector experts is seen as a cornerstone of strategic stability, and the group is pushing back against what it views as formulaic governance prescriptions.

RBC recently trimmed its price target on Munich Re to €560, maintaining a “Sector Perform” rating, citing currency risks and a normalising pricing environment in renewal rounds. The next major test for the stock comes on May 12, when the group reports first-quarter results — the first opportunity for investors to gauge whether the 2026 profit target remains on track amid the current market headwinds.